ОЦЕНКА БРЕМЕНИ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНИЛЕГКИХ(ХОБЛ)ИРОЛИ РАННЕЙ ДИАГНОСТИКИ ДЛЯ ЭФФЕКТИВНОГО ЛЕЧЕНИЯ ЭТОГОЗАБОЛЕВАНИЯ(Обзор литературы)

doi: 10.25005/3078-5022-2025-2-4-492-505
Авторы:
Х. МОХМАНД1,2К. И. ИКРОМЗОДА 2О. И. БОБОХОДЖАЕВ 2
1Медицинский факультет университета Балха, Мазори-Шариф, Афганистан,
2Кафедра фтизиопульмонологии ГОУ ТГМУ им. Абуали ибни Сино, Душанбе, Таджикистан

В данной статье представлен обзор литературы по бремени Хронической обструктивнойболезни легких (ХОБЛ) в разных странах мира. Описаны данные по эпидемиологии, патогенезу,факторам риска, генетической предрасположенности, патофизиологии, клинико-функциональнойманифестации и лечении ХОБЛ

Ключевые слова

Хроническая обструктивная болезнь легких, эпидемиология, патогенез,факторы риска, клинико-функциональная манифестация, лечение

Литература

  1. A literature review on the coexisting chronic obstructive pulmonary disease andheart failure[Text] / T. Tasha, A. Desai, A. Bajgain, A. Ali [et al.] // Cureus. – 2023. – No e47895.
  2. Adeloye D. Global, regional, and national prevalence of, and risk factors for, chronicobstructivepulmonary disease (COPD) in 2019: a systematic review and modelling analysis [Text] / D. Adeloye,P. Song, Y. Zhu // Lancet Respiratory Med. – 2022 - No10. (5). – pp. 447–458.
  3. Baba M.A. Exploring the treatment types and challenges in patients with chronicobstructivepulmonary disease: a qualitative study [Text] / MA. Baba, SE. Khan, F. Hasnain // MiddleEastJFam Med. – 2022. - No7. (10). - pp. 23.
  4. Burden of obstructive lung disease study in Iran: first report of the prevalence andriskfactorsofCOPD in five provinces [Text] / H. Sharifi, M. Ghanei, H. Jamaati, MR. Masjedi [et al.] // LungIndia J. – 2019. - No36. (1). - pp. 14.
  5. Burden of obstructive lung disease in Iran: Prevalence and risk factors for COPDinNorthofIran[Text] / H. Sharifi, M. Ghanei, H. Jamaati, MR. Masjedi [et al.] // Int J Prev Med. – 2020. –No11.-pp.78.
  6. Buric. DJ. Gender differences in specific trends of COPD mortality in Croatia. [Text] / DJ. Burić,M.Erceg, N. Antoljak // Public Health. – 2022. – No202. - pp. 26–31.
  7. Bouwens JDM. Diagnostic differentiation between asthma and COPD in primary careusinglungfunction testing [Text] // JDM. Bouwens, EWMA. Bischoff, JCCM. In 't Veen // NPJ PrimCareRespir Med. – 2022. - No32. (1). - pp. 32–39.
  8. Celli B. Definition and nomenclature of Chronic Obstructive Pulmonary Disease [Text] / B. Celli,L.Fabbri, G. Criner // Am J Respir Crit Care Med. – 2022. – No206. (11). – pp. 1317–1325.
  9. Chen X. Global, regional, and national burden of chronic respiratory diseases andassociatedriskfactors, 1990–2019: results from the global burden of Disease Study 2019 [Text] / X. ChenX, CW.Zhou, YY. Fu Y// Front Med. – 2023. - No10. – pp. e1066804.
  10. Chronic Obstructive Pulmonary Disease (COPD) in Population Studies in Russia andNorway:Comparison of Prevalence, Awareness and Management [Text] / C. Sarah, E. AnneElise, A.H.Laila, M. Sofia [et al.] // international Journal of Chronic Obstructive Disease. – 2021. –No16. -pp.1353-1368.
  11. Differences between man and woman with chronic obstructive disease [Text] / W. Zhufeng,L.Junfeng, L. Lina, H. Feifei [et al] // Respiratory Int. J. - 2025. - No10. – pp. e12931.
  12. Furian M. Effect of dexamethasone on nocturnal oxygenation in lowlanders with chronicobstructivepulmonary disease traveling to 3100 meters: a randomized clinical trial [Text] / M. Furian,M.Lichtblau, S.S. Aeschbacher // JAMA Netw Open. – 2019. - No2. – pp. e190067.
  13. Global strategy for the. diagnosis, management and prevention of chronic obstructivepulmonarydisease 2024 report // https://goldcopd.org/2024-gold-report/
  14. Global prevalence of chronic obstructive pulmonary disease: systematic reviewandmeta-analysis[Text] / M. Varmaghani, M. Dehghani, E. Heidari, F. Sharifi [et al.] // East Mediterr HealthJ. –2019.– No25. (1). - pp. 47–57.
  15. Gupta. P. Study of frequency of occurrence of cor-pulmonale among COPDpatients [Text] / P.Gupta,N. Mishra, S. Khari // International Journal for Multidisciplinary Research. – 2023. - No5. (6).
  16. Guo B. The changing and predicted trends in Chronic Obstructive Pulmonary DiseaseBurdeninChina, the United States, and India from 1990 to 2030 [Text] / B. Guo, H. Gan , M. Xue// Int.JChronic Obstr. Pulm Dis. – 2024. – No19695. – pp.706.
  17. Jenkins C. Differences between men and women with Chronic Obstructive PulmonaryDisease[Text]/ C. Jenkins // Clin Chest Med. – 2021. – No42. (3). - pp. 443–56.
  18. Joseph L. Harrison's Principles of Internal Medicine [Text] / L. Joseph, F. Anthony, K. Dennis,H.Stephen [et al.] // McGraw Hill. – 2022. – No13. – pp. 2977- 2995.
  19. Jo Y. S. Long-term outcome of chronic obstructive pulmonary disease: Areview[Text] / S.Y. Jo//Tuberculosis and Respiratory Diseases. – 2022. No85. (4). – pp. 289-301.
  20. Khan M.A. Feasibility of delivering integrated COPD-asthma care at primary and secondarylevelpublic healthcare facilities in Pakistan: a process evaluation. BJGP Open [Text] / MA. Khan, MA.Khan, JD. Walley // PMC free article, PubMed. – 2019. – No3. (1). – pp. 1810-1634.
  21. Kiani FZ. Prevalence of different comorbidities in chronic obstructive pulmonarydiseaseamongShahrekord PERSIAN cohort study in southwest Iran [Text] / FZ. Kiani, A. Ahmadi // Sci Rep.–2021. – No11. - pp. 1548.
  22. Kim M. Association between asthma/chronic obstructive pulmonary disease overlapsyndromeandhealthcare utilization among the US adult population [Text] / M. Kim, W. Tillis, P. Patel, R.M. Davis[et al.] // Curr Med Res Opin. -2019. Jul. – No35. (7). – pp. 1191-1196.
  23. Klinton JS. TB and COVID – public and private health sectors adapt to a newreality[Text]/JS.Klinton, C. Oga-Omenka, P. Heitkamp // J Clin Tuberc Other Mycobact Dis. – 2020. –No21. -pp.e100199.
  24. Management of chronic obstructive pulmonary disease (COPD) exacerbations inhospitalizedpatients from admission to discharge: A comprehensive review of therapeutic interventions[Text]/K.S. Khan, S. Jawaid, U.A. Memon, T. Perera [et al/] // Cureus. – 2023. No10. – pp. e7759, 43694.
  25. Matina S. Prevalence of Chronic Cor pulmonale in Chronic obstructive pulmonary diseasepatientsin a Teaching Hospital in Nepal [Text] / S. Matina, B. Suman, Sh. Rakshya, B.K. Dambar // Journalof Institute of Medicine Nepal. – 2019. - No41. (1). pp.15-19
  26. Mechanisms, pathophysiology and currently proposed treatments of chronic obstructivepulmonary disease [Text] / S.D. Rodrigues, C.M. Cunha, G.M. Soares, P.L. Silva[et al.]//Pharmaceuticals. - 2021. No14. (10). – pp. 979.
  27. Mortimer K. Household air pollution and COPD: cause and effect or confounding byother aspectsofpoverty? [Text] / K. Mortimer, M. Montes de Oca, S. Salvi // Int J Tuberculosis lungDisease:Official J. Int Union against Tuberculosis Lung Disease. – 2022. – No26. (3). - pp. 206–16.
  28. Ntritsos G. Gender-specific estimates of COPD prevalence: a systematic reviewandmeta-analysis[Text] / G. Ntritsos, J. Franek, L. Belbasis // Int J Chronic Obstr PulmDis. – 2018. –No13. –pp.1507–1514.
  29. Physical activity and chronic obstructive pulmonary disease: A scoping review[Text] / X. Xiang,L. Huang, Y. Fang, S. Cai [et al.] // BMC Pulmonary Medicine. – 2022. - No22. (1).
  30. Prevalence and attributable health burden of chronic respiratory diseases. 1990–2017[Text]/asystematic analysis for the global burden of Disease Study 2017 // Lancet RespiratoryMed. –2020-No8. (6). – pp. 585–596.
  31. Prevalence of chronic cor Pulmonale in chronic obstructive pulmonary disease patientsinateaching hospital in Nepal [Text] / M. Sayami, S. Baral, R. Shrestha, B.K. Dambar[et al.] // Journalof Institute of Medicine Nepal. – 2019. - No41. (1). – pp. 15-19.
  32. Principe R. Smoking cessation in the management of Chronic Obstructive PulmonaryDisease(COPD) [Text] / R. Principe, V. Zagà, P. Martucci // Annali dell’Istituto Superiore Di Sanita. –2024.- No60. (1). – pp. 14–28.
  33. Profile and preliminary results of Iranian sub cohort chronic obstructive pulmonary disease(COPD)in Shahrekord PERSIAN cohort in southwest Iran [Text] / Z.K. Fatemeh, A. Ali, S.B. Akbar[etal.]// BMC pulmonary medicine. – 2021. - No21. – pp. 2699.
  34. Relevance of cor Pulmonale in COPD with and without pulmonary hypertension:Aretrospective cohort Study [Text] / A. Yogeswaran, S. Kuhnert, H. Gall, M. Faber [et al.]//Frontiers in Cardiovascular Medicine. – 2022. - No9. – pp. e10.1002/pul2.12376.
  35. Russo P. Effect of cigarette smoking on clinical and molecular endpoints in COPDpatients[Text]/P.Russo, F. Milani, A. De Iure // Int J Mol Sci – 2024. - No25. (11). – pp. 10-3390.
  36. Safiri S. Burden of chronic obstructive pulmonary disease and its attributable riskfactorsin204countries and territories [Text] / S. Safiri, K. Carson-Chahhoud, M. Noori // BMJ Clinical Resed.–2022. – No378.
  37. Sana A. Chronic obstructive pulmonary disease associated with biomass fuel use in women[Text]/A. Sana A, SMA. Somda, N. Meda // BMJ open Respiratory Res. - 2018. - No5. (1). –pp. 246.
  38. Shengmai injection as an adjunctive therapy for the treatment of chronic obstructivepulmonarydisease: a systematic review and meta-analysis [Text] / X. Huang, X. Duan, K. Wang, J. Wu[etal.]// Complement Ther. Med. - 2019. - No43. - pp. 140-147.
  39. Tabyshova A. Prevalence, socio-economic burden and pharmacologic treatment of COPDinKyrgyzstan [Text] / A. Tabyshova // Int J Environ Res Pub Health. – 2022. - No17. –pp. 7483.
  40. Tauseef W. Frequency of Chronic COR Pulmonale in Patients with Chronic ObstructivePulmonaryDisease [Text] / W. Tauseef, A.K. ihtisham, //Indus Journal of Bioscience Research. –2025. –No3.(7). – pp.1152-1157.
  41. The coexistence of chronic obstructive pulmonary disease and heart failure [Text] / K. Khalid,J.Padda, A. Komissarov, L.B. Colaco [et al.] // Cureus. – 2021. - No10. – pp. e7759, 17387.
  42. Varmaghani M. Global prevalence of chronic obstructive pulmonary disease: systematicreviewandmeta-analysis [Text] / M. Varmaghani , M. Dehghani, E. Heidari // East MediterraneanHealthJ.-2019. – No25. (1). – pp. 47–57.
  43. World Health Organization. Global Adult Tobacco Survey (GATS) Russian Federation2009Country Report. Geneva, Switzerland: World Health Organization; 2010. [AccessedNovember11,2014]. Availablefrom: http://www.who.int/entity/tobacco/surveillance/en_tfi_gats_russian_countryreport.pdf
  44. Wu Y. Global burden of chronic obstructive pulmonary disease attributable to ambient particulatematter pollution and household air pollution from solid fuels from 1990 to 2019 [Text] / Y. Wu,S.Zhang , B. Zhuo // Environ Sci Pollut Res Int. – 2022. – No29. (22). – pp. e 3278899.
  45. Yang IA. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, andimplications for prevention and treatment [Text] / IA. Yang, CR. Jenkins, SS. Salvi // LancetRespiratory Med. – 2022. – No10. (5). – pp. 497–511.
  46. Yoon YS. Accelerated lung aging and chronic obstructive pulmonary disease [Text] / YoonYS,JinM, Sin DD // Expert Rev Respir Med. – 2019. Apr. – No13. (4). – pp. 369-380.

◄ Возврат к списку